BlackRock’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Buy
4,415,867
+510,534
+13% +$1.57M ﹤0.01% 3309
2025
Q4
$13.9M Buy
3,905,333
+470,458
+14% +$1.74M ﹤0.01% 3293
2025
Q3
$12M Buy
3,434,875
+127,971
+4% +$438K ﹤0.01% 3360
2025
Q2
$6.78M Buy
3,306,904
+3,044,554
+1,160% +$7.61M ﹤0.01% 3616
2025
Q1
$299K Buy
262,350
+8,759
+3% +$6.78K ﹤0.01% 4529
2024
Q4
$78.4K Buy
253,591
+651
+0.3% +$169 ﹤0.01% 4841
2024
Q3
$82.7K Buy
252,940
+48,126
+23% +$19.9K ﹤0.01% 4713
2024
Q2
$94.2K Buy
204,814
+55,383
+37% +$47.3K ﹤0.01% 4720
2024
Q1
$236K Sell
149,431
-88,415
-37% -$168K ﹤0.01% 4551
2023
Q4
$485K Hold
237,846
﹤0.01% 4431
2023
Q3
$333K Buy
237,846
+88,415
+59% +$91.5K ﹤0.01% 4533
2023
Q2
$82.2K Sell
149,431
-774,486
-84% -$410K ﹤0.01% 4979
2023
Q1
$626K Sell
923,917
-677,367
-42% -$864K ﹤0.01% 4478
2022
Q4
$2.64M Buy
1,601,284
+71,634
+5% +$201K ﹤0.01% 4011
2022
Q3
$7.08M Buy
1,529,650
+771,555
+102% +$4.54M ﹤0.01% 3600
2022
Q2
$3.84M Buy
+758,095
New +$5.52M ﹤0.01% 3943

Other funds holding TOI